Marcus (NYSE: MCS) insider transactions
In the twelve months to 10 November 2026, executives and directors of Marcus reported 5 open-market sales of 116,623 shares ($2.0m) and 1 open-market purchase of 33,915 shares ($0), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 23 September 2026 | Gershowitz Diane M | Director | Open-market sale | −50,000 | $27.61 | 125,617 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Option exercise | +24,400 | $27.00 | 236,316 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Shares withheld for tax | −20,875 | $31.56 | 215,441 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Option exercise | +39,000 | $28.88 | 254,441 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Shares withheld for tax | −35,848 | $31.43 | 218,593 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Option exercise | +47,100 | $21.84 | 265,693 | Form 4 |
| 3 August 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Shares withheld for tax | −32,728 | $31.43 | 232,965 | Form 4 |
| 25 June 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Option exercise | +50,000 | $17.04 | 253,639 | Form 4 |
| 25 June 2026 | Kissinger Thomas F | Sr Exec VP, Gen Counsel & Secy | Shares withheld for tax | −41,723 | $23.37 | 211,916 | Form 4 |
| 21 May 2026 | Marcus David John | Director | Grant or award | +1,391 | $17.97 | 106,476 | Form 4 |
| 21 May 2026 | Gershowitz Diane M | Director | Grant or award | +1,391 | $17.97 | 37,429 | Form 4 |
| 21 May 2026 | Hoeksema Timothy E | Director | Grant or award | +1,391 | $17.97 | 50,556 | Form 4 |
| 21 May 2026 | Leff Paul Adam | Director | Grant or award | +1,391 | $17.97 | 6,699 | Form 4 |
| 21 May 2026 | Milstein Philip L | Director | Grant or award | +1,391 | $17.97 | 79,149 | Form 4 |
| 21 May 2026 | Olson Bruce J | Director | Grant or award | +1,391 | $17.97 | 12,385 | Form 4 |
| 21 May 2026 | Ramirez Austin M | Director | Grant or award | +1,391 | $17.97 | 16,836 | Form 4 |
| 21 May 2026 | Selig Allan H | Director | Grant or award | +1,391 | $17.97 | 65,315 | Form 4 |
| 21 May 2026 | Stark Brian Jay | Director | Grant or award | +1,391 | $17.97 | 48,206 | Form 4 |
| 21 May 2026 | Gehl Katherine M. | Director | Grant or award | +1,391 | $17.97 | 18,472 | Form 4 |
| 1 May 2026 | Gramz Mark A | Pres., Marcus Theatres | Shares withheld for tax | −12,218 | — | 37,044 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Marcus page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.